basal insulin and glp 1 Improving drug-like properties of GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery glp-1_analogs [TUSOM | Pharmwiki]

Sebekov, K

The bottom line If youre carrying extra weight, the cancer news is good and its getting better, and the beautiful part is that the protection is mostly your own body getting healthier, not a drug doing something you cant see

However, a little cosmetic enhancement is no harm

(PubMed) Jeon YH, Park YH, Kwon JH, Lee JH, Kim IY

Its triple GIP/GLP-1/glucagon agonist mechanism produced the most striking weight-loss numbers ever reported in a Phase 2 trial of an injectable peptide, and its broad TRIUMPH Phase 3 program is poised to expand understanding of how triple receptor modulation affects obesity, diabetes, liver disease, cardiovascular risk, sleep apnea, and musculoskeletal health